Evidence map›Paper›PMID 38896390›Full record

ReviewInfectious diseases and therapy2024

The Incidence of Herpes Zoster Complications: A Systematic Literature Review.

Nikolaos Giannelos, Desmond Curran, Chi Nguyen, Carol Kagia, Nikki Vroom, Hilde Vroling

Abstract readReview
In one paragraph

Review in Infectious diseases and therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Observational
  4. Article
  5. Varicella zoster virus infection.Nature reviews. Disease primers · 2026
    Review
  6. Article
  7. Unlocking herpes zoster vaccination value in Finland: return on investment and actuarial model.The European journal of health economics : HEPAC : health economics in prevention and care · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Varicella zoster virus and the central nervous system.Nature reviews. Microbiology · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Acyclovir-unresponsive disseminated herpes zoster in B-cell chronic lymphocytic leukemia.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nikolaos GiannelosGSK, Wavre, Belgium. nikolaos.x.giannelos@gsk.com.ORCID http://orcid.org/0000-0001-9130-4744
Desmond CurranGSK, Wavre, Belgium.ORCID http://orcid.org/0000-0002-7423-0111
Chi NguyenPallas Health Research & Consultancy, a P95 Company, Leuven, Belgium.
Carol KagiaPallas Health Research & Consultancy, a P95 Company, Leuven, Belgium.ORCID http://orcid.org/0000-0003-3029-6642
Nikki VroomPallas Health Research & Consultancy, a P95 Company, Rotterdam, Netherlands.ORCID http://orcid.org/0000-0002-4571-5291
Hilde VrolingPallas Health Research & Consultancy, a P95 Company, Rotterdam, Netherlands.ORCID http://orcid.org/0000-0002-5840-3676

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe objective of this work was to summarize the incidence of herpes zoster (HZ) complications in different populations.

methodsSystematic literature review of PubMed, Embase, and Virtual Health Library records between January 1, 2002 and October 20, 2022 using search strings for HZ, complications, and frequency measurements.

resultsThe review included 124 studies, most conducted in the general population (n = 93) and on individuals with comorbidities (n = 41) ≥ 18 years of age. Most studies were conducted in Europe (n = 44), Asia (n = 40), and North America (n = 36). Postherpetic neuralgia (PHN) was the most studied neurological complication. Variable relative PHN incidence was found in the general population (2.6-46.7%) or based on diagnosis: immunocompromised (3.9-33.8%), depression (0-50%), and human immunodeficiency virus (HIV) (6.1-40.2%). High incidence rates were observed in hematological malignancies (HM) and solid organ malignancies (132.5 and 93.7 per 1000 person-years, respectively). Ocular complications were frequently reported with herpes zoster ophthalmicus (HZO). The relative incidence (incidence rate) of HZO in the general population was reported as 1.4-15.9% (0.31-0.35 per 1000 person-years). High relative incidence was observed in HIV (up to 10.1%) and HM (3.2-11.3%). Disseminated HZ was the most frequently reported cutaneous complication. The relative incidence of disseminated HZ was 0.3-8.2% in the general population, 0-0.5% in the immunocompetent, and 0-20.6% in patients with comorbidities. High relative incidence was reported in HM and solid organ transplant (up to 19.3% and 14.8%, respectively). DISCUSSION: Most reported complications were neurological (n = 110), ocular (n = 48), and cutaneous (n = 38). Few studies stratified complications by age or gender (or both). Incidence appeared higher in select immunocompromised populations. Higher incidence was associated with older age in several studies; the general association with gender was unclear.

conclusionsVariable incidence of HZ complications was reported by population subgroup. Further research is required to quantitatively analyze incidence by age, gender, and location.

Indexed as

ComplicationsHerpes zosterIncidencePHNSystematic reviewVaricella-zoster virus

Identifiers

PMID38896390
PMCPMC11219681

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.